Oncology Episode Payment Model in Hawaii
The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Feb 20, 2026 · Source: ClinicalTrials.gov
The study is underway but is not accepting new participants.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Pennsylvania
- Interventions being studied
- Other: Cancer Episode Payment Model (CEM)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
Any oncologist who practices with Hawaii Oncology and is a participating provider.
Any provider who does not practice with Hawaii Oncology.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Hawaii OncologyHonolulu, Hawaii
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 20, 2026. Always confirm current availability with the study team.